# Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dosing-of-rapamycin-is-critical-to-achieve-an-optimal-antiangiogenic-effect/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Markus Guba,Gudrun E. Koehl,Evelyn Neppl,Axel Doenecke,Markus Steinbauer,Hans J. Schlitt,Karl‐Walter Jauch,Edward K. Geissler |
| Citations | 93 |
| DOI | 10.1111/j.1432-2277.2004.00026.x |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2029225165 |
| PMID | 15612989 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Markus Steinbauer](https://scholariq.org/researchers/markus-steinbauer/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.